Both serum IGF-1 and insulin levels were positively correlated with serum IGFBP-3 levels (r = .34, P = .009 and r = .34, P = .008, respectively)
Avoiding high-calorie snacks, sugary drinks, fried foods, and large portions can lead to more effective results
Oral GLP-1 therapies activate GLP-1 receptors to boost insulin secretion, slow gastric emptying, and reduce appetite, leading to weight loss and improved glucose control
Its important to note that chest pain can stem from various causes, and semaglutide may only be a contributing factor in some cases
Human insulin (10 mU/kg/min, NovoRapid, Novo Nordisk) infusate containing d-[3-3H]-glucose was then administered, and blood glucose levels were titrated with 50% dextrose to achieve and maintain euglycemia
Others use GLP-1 as a tool to reach their goal and then transition to dietary management